Amifostine vs no intervention
Acute and late GI toxicity (grade 2+) · People with urological, gynaecological or colorectal cancer
Summary of findings: Amifostine may leads to lower acute and late GI toxicity (grade 2+) compared with no intervention (low certainty).
1 finding from 1 review
- Interventions to reduce acute and late adverse gastrointestinal effects of pelvic radiotherapy for primary pelvic… 2018 · Cochrane Headline outcomes onlyRR 0.253 studies · 278 participantsLow